Published On: Jun 15, 2016
A research report on the global equine healthcare market, published by Transparency Market Research (TMR), estimates the market to decline at a CAGR of 1.20% during the period from 2013 and 2019. In 2012, the market had a value of US$26.6 bn, which is expected to drop to US$24.5 bn by the end of the forecast period. The research report is titled “Equine Healthcare Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.”
Browse the full Equine Healthcare Market (Diagnostic Products, Therapeutic Products and Supplement Products) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 report at https://www.transparencymarketresearch.com/equine-healthcare-market.html
Equine healthcare refers to the practices and activities aimed at the upkeep of horses. From day-to-day care of hooves to maintaining the internal health of horses, equine healthcare includes a number of activities, diagnosis, therapies, and supplements. The equine healthcare market makes a large part of the multi-billion dollars’ worth global equestrian market. The trends in the equestrian market directly influence the market for equine healthcare.
According to the study, the sharp decline in the worldwide equestrian market has impacted negatively the global equine healthcare market, resulting in a swift drop in the market’s valuation.The report broadly classifies the global equine healthcare market into equine supplement products, equine diagnostic products, and equine therapeutic products. The equine diagnostic products market comprises equine pregnancy and gestation diagnostic products and equine genotyping analysis products.
Equine urine test kits and equine ultrasound devices are the major equine pregnancy and gestation diagnostic products available in the market. Genetic disease identification products/semen quality analyzers and breed quality analyzers/genotype analyzers kits are the main gestation diagnostic products and equine genotyping analysis products present in this market.
The equine supplement products market includes equine protection products and equine performance supplements. Equine proteins and amino acids supplements, equine electrolyte supplements, equine vitamin supplements, and various other equine performance supplements are the major components of the equine performance supplements segment. Equine prosthetics and other protection products are prime equine protection products available in the global market.
The equine therapeutic products market consists of equine antivirals, equine antibacterials, equine dopamine agonists, equine antiprotozoals, equine vaccines, equine anti-inflammatory drugs, and equine laxatives.
An assessment of the worldwide market for equine healthcare on a regional basis has also been provided in this research report. Regionally, the report has segmented this market into North America, Europe, Asia Pacific, and the Rest of the World. Analysts project Asia Pacific to emerge as the dominant regional market for equine healthcare over the forecast period. The increased horse breeding in Australia is likely to support the Asia Pacific equine healthcare market in the coming years.
China is anticipated to lead the Asia Pacific market in the near future equine on account of the increasing import of well-bred horses from various parts of the world. The country is taking a number of initiatives to support equine sports and is investing heavily in the maintenance of the thoroughbred species of horses. These factors are also expected to drive the Asia Pacific equine healthcare market significantly over the next few years, states the research report.
In conclusion, the report presents an analysis of the competitive landscape of the global equine healthcare market by profiling the key participants in this market. Zoetis Inc., Signostics Ltd., Purina Mills LLC, Merck Animal Health, Equine Products (UK) Ltd., Equine Orthotics and Prosthetics, Equine Diagnostics, Elanco Animal Health, Boerhringer Ingelheim Vetmedica Inc., Bayer Healthcare, and Affymetrix Inc. are the leading market players, profiled in this study.
The global equine healthcare market is segmented into:
- Equine Pregnancy and Gestation Diagnostic Products Market
- Equine UltraSound Devices Market
- Equine Urine Test Kits Market
- Equine Genotyping Analysis Products Market
- Breed Quality Analyzers/Genotype Analyzers Kits Market
- Genetic Disease Identification Products/Semen Quality Analyzers Market
Equine Therapeutic Products
- Equine Vaccines Market
- Equine Antibacterials Market
- Equine Antivirals Market
- Equine Antiprotozoals Market
- Equine Dopamine Agonists Market
- Equine Anti-inflammatory Drugs Market
- Equine Laxatives Market
Equine Supplement Products
- Equine Performance Supplements Market
- Equine Proteins and Amino Acids Supplements Market
- Equine Vitamin Supplements Market
- Equine Electrolyte Supplements Market
- Other Equine Performance Supplements Market
- Equine Protection Products Market
- Equine Protection Products Market
- Equine Prosthetics Market
Equine Healthcare Market, by Geography
- North America
- Rest of the World (RoW)
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453